A. D. Yalcin Et Al. , "The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment," World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization , vol.68, Milan, Italy, pp.675, 2013
Yalcin, A. D. Et Al. 2013. The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment. World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization , (Milan, Italy), 675.
Yalcin, A. D., Genc, G. E., Cilli, A., & Saadet, G., (2013). The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment . World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization (pp.675). Milan, Italy
Yalcin, A. Et Al. "The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment," World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization, Milan, Italy, 2013
Yalcin, A. D. Et Al. "The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment." World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization , Milan, Italy, pp.675, 2013
Yalcin, A. D. Et Al. (2013) . "The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment." World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization , Milan, Italy, p.675.
@conferencepaper{conferencepaper, author={A. D. Yalcin Et Al. }, title={The effect of eosinophil cationic peptid, soluble CD200, 25-hydroxyvitamin D, IL1 beta, TGF- beta, CXCL8 and G-CSF levels in asthma patients with the omalizumab treatment}, congress name={World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization}, city={Milan}, country={Italy}, year={2013}, pages={675} }